Sign Up to like & get
recommendations!
0
Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1253
Abstract: Abstract Background The new β-lactamase inhibitor, avibactam (AVI), has recently been combined with ceftazidime (CAZ) as CAZ-AVI. AVI is also in Phase 3 clinical trials combined with aztreonam as ATM-AVI. Both drug combinations have similar…
read more here.
Keywords:
100 100;
caz avi;
atm avi;
avi ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Addiction"
DOI: 10.1111/add.15871
Abstract: BACKGROUND AND AIMS Variation in the TAS2R38 taste receptor gene alters the ability to taste bitter compounds. We tested whether TAS2R38 variation influences early smoking behaviors in adolescence, a critical period of acquisition when taste…
read more here.
Keywords:
genetic variation;
avi;
taste;
variation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Antibiotics"
DOI: 10.3390/antibiotics12050820
Abstract: Abstract Background: Ceftazidime/avibactam (CAZ-AVI) resistance amongst Enterobacterales is worryingly increasing worldwide. Objectives: The aim of this study was to collect and describe real-life data on CAZ-AVI-resistant Klebsiella pneumoniae (KP) isolates in our University Hospital, with…
read more here.
Keywords:
avi;
caz avi;
group;
resistance ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Antibiotics"
DOI: 10.3390/antibiotics9120912
Abstract: Ceftazidime-avibactam (CAZ-AVI) and aztreonam-avibactam (AZT-AVI) are novel antibiotic combinations active against multidrug-resistant Gram-negative pathogens. This study aimed to evaluate their in vitro activities and inoculum effects in carbapenem-resistant Enterobacterales (CRE), including carbapenemase-producing (CP)-CRE and non-CP-CRE.…
read more here.
Keywords:
carbapenem resistant;
azt avi;
avi;
caz avi ... See more keywords